Compare IKT & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IKT | CURI |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.9M | 257.8M |
| IPO Year | 2020 | N/A |
| Metric | IKT | CURI |
|---|---|---|
| Price | $1.54 | $4.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.00 | ★ $6.00 |
| AVG Volume (30 Days) | 411.5K | ★ 768.8K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 6.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $66,595,000.00 |
| Revenue This Year | N/A | $42.19 |
| Revenue Next Year | N/A | $7.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 28.62 |
| 52 Week Low | $1.33 | $1.47 |
| 52 Week High | $4.20 | $7.15 |
| Indicator | IKT | CURI |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 50.58 |
| Support Level | $1.43 | $4.42 |
| Resistance Level | $1.57 | $5.00 |
| Average True Range (ATR) | 0.10 | 0.23 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 73.81 | 34.48 |
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.